Single logo

Pharmaceutical Pharmacovigilance System Audit Checklist

A comprehensive checklist for auditing pharmaceutical pharmacovigilance systems to ensure compliance with global regulations, maintain effective drug safety monitoring, and protect patient safety throughout the product lifecycle.

Pharmaceutical Pharmacovigilance System Audit Checklist
by: audit-now
4.2

Get Template

About This Checklist

The Pharmaceutical Pharmacovigilance System Audit Checklist is an essential tool for ensuring the effectiveness, compliance, and reliability of drug safety monitoring processes. This comprehensive checklist addresses key aspects of pharmacovigilance, from adverse event reporting to signal detection and risk management, helping to maintain patient safety and regulatory compliance. By implementing this checklist, pharmaceutical companies can enhance their pharmacovigilance practices, meet global regulatory requirements, and demonstrate their commitment to ongoing drug safety monitoring throughout the product lifecycle.

Learn more

Industry

Pharmaceuticals

Standard

EMA Guideline on good pharmacovigilance practices (GVP) and FDA Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment

Workspaces

Clinical trial sites

Occupations

Pharmacovigilance Officer
Drug Safety Physician
Quality Assurance Specialist
Regulatory Affairs Manager
Clinical Safety Scientist

Pharmacovigilance System Audit

(0 / 4)

1
Describe the procedures for safety communication.

Provide detailed procedures.

To evaluate the effectiveness of communication regarding drug safety information.
Write something awesome...
2
Is there an active risk management plan in place?

Indicate whether an active risk management plan exists.

To confirm that risk management strategies are being implemented effectively.
3
What is the frequency of signal detection activities performed?

Enter frequency in months.

To assess the proactive measures taken for drug safety monitoring.
Min: 1
Target: 12
Max: 12
4
Is the adverse event reporting process compliant with regulatory requirements?

Select compliance status.

To ensure adherence to legal and regulatory standards for reporting adverse events.
5
What improvements have been identified from the last audit?

Provide details of identified improvements.

To document findings and enhance the pharmacovigilance system.
Write something awesome...
6
When was the last quality audit conducted?

Select the date of the last quality audit.

To ensure regular assessment of the pharmacovigilance quality system.
7
What is the average delay in adverse event reporting (in days)?

Enter the average delay in days.

To assess the timeliness of adverse event reporting.
Min: 0
Target: 5
Max: 30
8
Is the pharmacovigilance quality system compliant with GVP and FDA guidelines?

Select compliance status.

To verify that the quality system meets established pharmacovigilance standards.
9
Describe the communication plan for stakeholders regarding safety updates.

Provide details of the communication plan.

To assess how effectively safety information is communicated to relevant stakeholders.
Write something awesome...
10
Have safety review meetings been conducted regularly?

Indicate whether safety review meetings are being held.

To confirm that the organization is actively discussing safety issues and updates.
11
How often are risk assessments conducted (in months)?

Enter frequency in months.

To evaluate the regularity of risk assessments as part of the risk management process.
Min: 1
Target: 6
Max: 12
12
Is the current risk management plan actively implemented?

Select the status of the risk management plan.

To ensure that the risk management plan is not only created but also actively enforced.
13
What challenges have been encountered in data management?

Provide details on data management challenges.

To identify areas of improvement within the data management processes.
Write something awesome...
14
When was the last data quality audit conducted?

Select the date of the last data quality audit.

To ensure that data quality is regularly assessed and improved.
15
What is the average time taken for data entry (in hours) after an event is reported?

Enter average time in hours.

To evaluate the efficiency of data entry processes.
Min: 0
Target: 24
Max: 72
16
Is there a process in place for verifying the accuracy of adverse event data?

Select the status of data accuracy verification.

To ensure that data integrity is maintained throughout the reporting process.
17
What feedback have staff provided regarding the training programs?

Provide detailed feedback from staff.

To gather insights for improving training effectiveness and relevance.
Write something awesome...
18
Are ongoing training sessions held regularly for staff?

Indicate whether ongoing training sessions are conducted.

To ensure continuous education and awareness about pharmacovigilance updates.
19
What is the current training completion rate among pharmacovigilance staff (in percentage)?

Enter the completion rate as a percentage.

To assess the effectiveness of the training program and staff engagement.
Min: 0
Target: 85
Max: 100
20
Is there a training program available for pharmacovigilance staff?

Select the availability status of the training program.

To ensure that staff are adequately trained in pharmacovigilance practices.

FAQs

The checklist covers key areas such as adverse event collection and reporting, database management, signal detection methodologies, risk management planning, safety communication procedures, quality management system, and training programs.

Pharmacovigilance system audits should be conducted at least annually, with more frequent audits for specific processes or in preparation for regulatory inspections.

Pharmacovigilance system audits are typically conducted by internal quality assurance personnel, dedicated pharmacovigilance auditors, or external consultants with expertise in drug safety and regulatory requirements.

Non-compliance issues can lead to regulatory actions, including fines, marketing authorization suspensions, reputational damage, and potential legal liabilities if safety issues are not properly identified and addressed.

By ensuring comprehensive and compliant pharmacovigilance practices, this checklist helps maintain robust safety monitoring, facilitates early detection of potential safety signals, and supports timely implementation of risk minimization measures to protect patient safety.

Benefits

Ensures compliance with global pharmacovigilance regulations and guidelines

Improves the efficiency and effectiveness of adverse event reporting and processing

Enhances signal detection and evaluation processes

Supports timely and accurate safety communications to stakeholders

Facilitates continuous improvement of the pharmacovigilance system